Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1411-1420 of 1,553) with videos related to

Pageof 156
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2025
Erdafitinib in Patients with FGFR-altered Advanced or Metastatic CholangiocarcinomaShubham Pant, Joon Oh Park, Wu-Chou Su, et al.
The Oncologist|December 8, 2022
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter StudyJian Li, Xinhua Zhang, Yanhong Deng, et al.
Parkinsonism & Related Disorders|June 4, 2015
The association between infectious burden and Parkinson's disease: A case-control studyXian-Le Bu, Xin Wang, Yang Xiang, et al.
NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.
Iscience|November 22, 2019
Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric CancerMengsha Tong, Chunyu Yu, Jinwen Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2017
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA StudyJianming Xu, Tae Won Kim, Lin Shen, et al.
Oncotarget|February 5, 2017
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I studyJian Ming Xu, Yan Wang, Yu Ling Chen, et al.
Journal of the National Cancer Institute|June 14, 2014
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroupsWen-Qing Li, Jun-Ling Ma, Lian Zhang, et al.
Targeted Oncology|September 4, 2024
A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or LymphomaJifang Gong, Ye Guo, Yanqiao Zhang, et al.
Pageof 156

Showing results (1411-1420 of 1,553) with videos related to

Sort By:
Pageof 156
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2025
Erdafitinib in Patients with FGFR-altered Advanced or Metastatic CholangiocarcinomaShubham Pant, Joon Oh Park, Wu-Chou Su, et al.
The Oncologist|December 8, 2022
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter StudyJian Li, Xinhua Zhang, Yanhong Deng, et al.
Parkinsonism & Related Disorders|June 4, 2015
The association between infectious burden and Parkinson's disease: A case-control studyXian-Le Bu, Xin Wang, Yang Xiang, et al.
NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.
Iscience|November 22, 2019
Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric CancerMengsha Tong, Chunyu Yu, Jinwen Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2017
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA StudyJianming Xu, Tae Won Kim, Lin Shen, et al.
Oncotarget|February 5, 2017
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I studyJian Ming Xu, Yan Wang, Yu Ling Chen, et al.
Journal of the National Cancer Institute|June 14, 2014
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroupsWen-Qing Li, Jun-Ling Ma, Lian Zhang, et al.
Targeted Oncology|September 4, 2024
A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or LymphomaJifang Gong, Ye Guo, Yanqiao Zhang, et al.
Pageof 156